Artemis Medicare Services Adjusts Evaluation Amid Strong Growth and Ongoing Challenges
Artemis Medicare Services has experienced a recent evaluation adjustment due to various financial trends. The company reported significant annual growth in operating profit and net profit, alongside consistent positive results over the last seven quarters. However, challenges such as low return on equity and pledged promoter shares persist.
Artemis Medicare Services has recently undergone an evaluation adjustment, reflecting a revision in its score. This change is attributed to various underlying trends and financial metrics that have been observed over recent periods. The company operates within the hospital and healthcare services industry and has demonstrated a notable operating profit growth rate of 82.15% annually. Additionally, net profit has increased by 41.51%, contributing to a positive financial performance for the quarter ending September 2025. The company has consistently reported positive results for the last seven consecutive quarters, with operating cash flow reaching its highest at Rs 139.08 crore.
Despite these positive indicators, Artemis Medicare has faced challenges, including a low return on equity (ROE) of 9.9% and a significant portion of promoter shares being pledged, which may exert downward pressure on stock prices in adverse market conditions. The stock has generated a return of -3.85% over the past year, underperforming the broader market, which has seen a return of 6.33%.
Overall, the evaluation adjustment reflects a complex interplay of positive growth metrics and underlying challenges that characterize Artemis Medicare Services' current market position.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
